Home › Funds › D. E. Shaw & Co › SPRY
D. E. Shaw & Co position in SPRY
ARS PHARMACEUTICALS INC · Health Care
Latest position (Q1 2026)11.87K sh
Reported value held$95.34K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 250.58K | $2.50M | New |
| Q4 2021 | 250.02K | $1.67M | Hold |
| Q1 2022 | 187.32K | $658.00K | Reduce |
| Q2 2022 | 92.12K | $391.00K | Reduce |
| Q3 2022 | 29.29K | $155.00K | Reduce |
| Q4 2022 | 43.70K | $372.74K | Add |
| Q1 2023 | 24.30K | $158.21K | Reduce |
| Q1 2024 | 38.18K | $390.17K | New |
| Q2 2024 | 68.23K | $580.66K | Add |
| Q3 2024 | 80.55K | $1.17M | Add |
| Q4 2024 | 76.73K | $809.52K | Reduce |
| Q1 2025 | 33.80K | $425.17K | Reduce |
| Q2 2025 | 57.45K | $1.00M | Add |
| Q3 2025 | 34.22K | $343.90K | Reduce |
| Q4 2025 | 26.53K | $309.04K | Reduce |
| Q1 2026 | 11.87K | $95.34K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SPRY
- BlackRock Inc 5.31M sh · $42.54M · Q2 2026
- Vanguard Group 3.51M sh · $40.88M · Q4 2025
- Capital World Investors 2.75M sh · $22.07M · Q2 2026
- Millennium Management 2.52M sh · $20.19M · Q2 2026
- UBS Group AG 1.94M sh · $15.54M · Q2 2026
- Geode Capital Management 1.70M sh · $13.61M · Q2 2026
- Third Point 1.00M sh · $8.01M · Q2 2026
- Charles Schwab Investment Management 551.42K sh · $4.42M · Q2 2026
- Northern Trust Corp 549.06K sh · $4.40M · Q2 2026
- Bank of America Corp 463.26K sh · $3.71M · Q2 2026
- Fidelity International (FIL) 455.57K sh · $3.65M · Q2 2026
- JPMorgan Chase & Co 363.32K sh · $3.11M · Q2 2026